Lymphoma Leukemia
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL (NCT05114837) | Masonic Cancer Center, University of Minnesota | 2024-09-01 |
| To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames (NCT03975205) | Sutphin Drugs | 2019-07-01 |
| Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma (NCT03811457) | UWELL Biopharma | 2017-06-01 |
Track Lymphoma Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.